Connect Sign In
Four different algorithms to lead clinicians through the correct approach to thyroid testing are available on arupconsult.com.
Lab testing is key to thyroid disease diagnosis and proper treatment but can be challenging. ARUP Consult’s thyroid disease testing resources are divided into easy-to-navigate topics and algorithms.
Next generation sequencing provides a more rigorous and sensitive method to identify drug-resistant variants of cytomegalovirus, which enables earlier detection and more effective treatment.
ARUP has gained a Conformité Européenne (CE) mark for AAV5 DetectCDx™ single-site use. The test will aid in determining the eligibility of non-U.S. patients for a new hemophilia A gene therapy.
The newest edition highlights innovations that keep ARUP at the forefront of toxicology testing. Also featured: ARUP’s expanded capacity for cytogenetics testing.
A platform clients use to reduce testing waste, lower cost per test, and improve patient safety has won the prestigious Choosing Wisely Champion Award from the American Society for Clinical Pathology.
ARUP Consult, a free source of expert guidance in laboratory testing, has released new resources on testing for polycystic ovary syndrome and autoimmune encephalitis.
ARUP Consult, a free source of expert guidance in laboratory testing, has released updated resources on testing for osteoporosis, paraneoplastic pemphigus, and epilepsy.
ARUP Consult, a free source of expert guidance in laboratory testing, has released updated resources on testing for Lyme disease, diagnosing pneumonia, and evaluating infertility.
ARUP Consult, a free source of expert guidance in laboratory testing, has updated resources on testing for human papillomavirus, chronic lymphocytic leukemia, and amenorrhea.
ARUP Laboratories has received FDA approval for its companion diagnostic immunoassay, AAV5 DetectCDx™, which helps determine patient eligibility for a new gene therapy for severe hemophilia A.
ARUP’s Clinical Trials and PharmaDx groups supported Blueprint Medicines’ clinical trials that led to FDA approval for AYVAKIT® (avapritinib), a new treatment for indolent systemic mastocytosis.
ARUP Consult, a free source of expert guidance in laboratory testing, has updated resources on autoimmune neurologic diseases, drug detection in newborns, and common variable immunodeficiency.
